Researchers at the National Institutes of Health have developed a new, less invasive way to perform transcatheter aortic valve replacement (TAVR), a procedure widely used to treat aortic valve stenosis, a lethal heart condition. The new approach, called transcaval access, will make TAVR more available to high risk patients, especially women, whose femoral arteries are too small or diseased to withstand the standard procedure. The Journal of the American College of Cardiology published the findings.
Related posts:
- Medicare Card, NIH scientists find rare disease clues in cell’s recycling system Medicare Card, NIH scientists find rare disease clues in cell’s recycling system...
- Medicare Card, Genetics of type 2 diabetes revealed in unprecedented detail Medicare Card, Genetics of type 2 diabetes revealed in unprecedented detail...
- Scientists identify likely predictors of hepatitis C severity Scientists at the National Institutes of Health have identified several factors in people infected with the hepatitis C virus that may predict whether the unusually rapid progression of disease from initial infection to severe liver conditions, such as cirrhosis, will occur. Knowing whether a patient’s condition is likely to deteriorate quickly could help physicians decide […]...
- Medicare Card, NIH study determines key differences between allergic and non-allergic dust mite proteins Medicare Card, NIH study determines key differences between allergic and non-allergic dust mite proteins...
- Medicare Card, NIH funds next step of cutting-edge research into Alzheimer’s disease genome Teams of scientists will use support from the National Institutes of Health to conduct research into the genetic underpinnings of Alzheimer’s disease, analyzing how genome sequences — the order of chemical letters in a cell’s DNA — may contribute to increased risk or protect against the disease. The NIH awarded grants for using innovative new […]...
- Medicare Card, Underlying genetics, marker for stroke, cardiovascular disease Medicare Card, Underlying genetics, marker for stroke, cardiovascular disease...
- Medicare Card, Experimental treatment for Niemann-Pick disease Medicare Card, Experimental treatment for Niemann-Pick disease...
- Neuroscience Advances Showcased in Washington Dr. Insel reflects on an exciting neuroscience conference where an increasing interest in neuropsychiatric disorders was evident....
- NIAAA researcher wins prestigious neuroscience prize Xin Jin, Ph.D., a postdoctoral fellow at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, received the Peter and Patricia Gruber International Research Award from the Society for Neuroscience today during the society@apos;s annual meeting in Washington, D.C....
- Medicare Card, NIH scientists map first steps in flu antibody development Medicare Card, NIH scientists map first steps in flu antibody development...
- Medicare Card, NIH scientists uncover how immune cells sense who they are Medicare Card, NIH scientists uncover how immune cells sense who they are...
- Medicare Card, Scientists Don’t Know What Causes Amyotrophic Lateral Sclerosis Medicare Card, Scientists Don't Know What Causes Amyotrophic Lateral Sclerosis ...
- Medicare Card, NIH scientists shed light on mystery surrounding hepatitis B virus Medicare Card, NIH scientists shed light on mystery surrounding hepatitis B virus...
- Medicare Card, Scientists fish for new epilepsy model and reel in potential drug Medicare Card, Scientists fish for new epilepsy model and reel in potential drug...
- Medicare Card,NIH scientists develop candidate vaccine against respiratory syncytial virus An experimental vaccine to protect against respiratory syncytial virus (RSV), a leading cause of illness and hospitalization among very young children, elicited high levels of RSV-specific antibodies when tested in animals, according to a report in the journal Science....